Physician profile
Agostino Cervone
NPI 1841206018
$93,817.70
in general payments reported to CMS, 2019-2025
21 companies · $7,661 in 2025
The $7,661 reported for 2025 was more than what 93% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,689 · 2020: $182 · 2021: $594 · 2022: $41K · 2023: $19K · 2024: $17K · 2025: $7,661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $24K · Consulting Fee: $8,700 · Travel and Lodging: $5,518 · Food and Beverage: $4,308 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500 · Honoraria: $520 · Gift: $31.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $24,000.00 |
| Consulting Fee | $8,700.00 |
| Travel and Lodging | $5,517.54 |
| Food and Beverage | $4,308.38 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
| Honoraria | $520.00 |
| Gift | $31.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $69,179.47 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $17,650.00 | 2019-2024 | |
| Davol INC. | $3,019.30 | 2021-2025 | Phasix Mesh |
| Ethicon INC. | $1,000.00 | 2024-2025 | |
| Medtronic, INC. | $382.17 | 2021-2025 | Transorb, Endurant Iis |
| Dilon Technologies, INC. | $341.98 | 2025 | Hemoblast Bellows |
| Smith+Nephew, INC. | $340.35 | 2019-2021 | |
| Organogenesis INC. | $243.58 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $241.50 | 2021-2024 | Gore Synecor Biomaterial |
| Asensus Surgical, INC. | $239.90 | 2019 | |
| Covidien LP | $225.81 | 2019-2020 | |
| Polynovo North America LLC | $179.57 | 2025 | Novosorb Btm |
| Ethicon Endo-Surgery INC. | $150.00 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $125.00 | 2025 | |
| Innocoll Pharmaceuticals Limited | $112.20 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endogastric Solutions, INC | $110.43 | 2019 | |
| Acell, INC. | $106.38 | 2019 | |
| Avanos Medical | $100.76 | 2022 | |
| Merck Sharp & Dohme LLC | $27.20 | 2019-2020 | |
| Integra Lifesciences Corporation | $26.50 | 2024 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Mesh Suture INC | $15.60 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Agostino Cervone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.